Utah Medical Products
UTMD
90 hedge funds and large institutions have $263M invested in Utah Medical Products in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 9 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 22
5.41% more ownership
Funds ownership: 69.34% → 74.76% (+5.4%)
2% less funds holding
Funds holding: 92 → 90 (-2)
8% less capital invested
Capital invested by funds: $285M → $263M (-$22.2M)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$5.55M |
| 2 |
Lazard Asset Management
New York
|
+$4.06M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.64M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.61M |
| 5 |
Renaissance Technologies
New York
|
+$2.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.85M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$671K |
| 3 |
BPM
Bowling Portfolio Management
Cincinnati,
Ohio
|
-$649K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$576K |
| 5 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
-$458K |
UTMD Hedge Fund Activity: Q3 2018 in Review
90 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2018, worth a combined $263M — down 7.8% from $285M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of UTMD and 7 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 36 added.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $5.55M. The largest seller was Fidelity Investments, cutting an estimated $3.85M.
- 90 institutional investors held Utah Medical Products (UTMD) as of Q3 2018, down from 92 in Q2 2018.
- Funds reported $263M of Utah Medical Products stock for Q3 2018, down 7.8% quarter-over-quarter.
- 7 funds opened new Utah Medical Products positions in Q3 2018 and 9 closed out, a net change of -2 holders.
- The largest Utah Medical Products buyer in Q3 2018 was Loomis, Sayles & Company, an estimated $5.55M added.
- The largest Utah Medical Products seller in Q3 2018 was Fidelity Investments, an estimated $3.85M sold.
Based on aggregated 13F filings for Q3 2018.